A Multicenter, Open-Label Trial to Assess the Safety and Tolerability of a Single Intravenous Loading Dose of Lacosamide Followed by Oral Maintenance as Adjunctive Therapy In Patients With Partial-Onset Seizures

被引：0
|
作者：
Fountain, N. B.
Krauss, G.
Isojarvi, J.
Dilley, D.
Doty, P.
Rudd, G.
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Schwarz Biosci, Raleigh, NC USA
来源：
ANNALS OF EMERGENCY MEDICINE | 2010年 / 56卷 / 03期
关键词：
D O I：
10.1016/j.annemergmed.2010.06.139
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures
    Lerche, Holger
    Daniluk, Jerzy
    Lotay, Narinder
    DeRossett, Sarah
    Edwards, Suzanne
    Brandt, Christian
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 30 : 93 - 100
  • [32] Multicenter open-label trial investigating safety and tolerability of intravenous SPM 927 as replacement for oral SPM 927 in subjects with partial seizures
    Vaiciene, N.
    Mameniskiene, R.
    Biton, V.
    Brock, M.
    Sommerville, K.
    EPILEPSIA, 2006, 47 : 146 - 146
  • [33] SEIZURE FREEDOM IN ADULTS WITH PARTIAL-ONSET SEIZURES TREATED WITH ADJUNCTIVE LACOSAMIDE: POOLED ANALYSIS OF THREE OPEN-LABEL EXTENSION TRIALS
    Dimova, S.
    McShea, C.
    De Backer, M.
    EPILEPSIA, 2013, 54 : 173 - 174
  • [34] LACOSAMIDE: AN INTERIM EVALUATION OF LONG-TERM SAFETY AND EFFICACY AS ORAL ADJUNCTIVE THERAPY IN SUBJECTS WITH PARTIAL-ONSET SEIZURES
    Rosenfeld, W.
    Fountain, N.
    Kaubrys, G.
    Heinzen, L.
    McShea, C.
    EPILEPSIA, 2009, 50 : 111 - 111
  • [35] Lacosamide: An interim evaluation of long-term safety and efficacy as oral adjunctive therapy in subjects with partial-onset seizures
    Rosenfeld, William
    Fountain, N. B.
    Kaubrys, G.
    Heinzen, L.
    McShea, C.
    EPILEPSIA, 2007, 48 : 318 - 319
  • [36] Lacosamide: an interim evaluation of long-term safety and efficacy as oral adjunctive therapy in subjects with partial-onset seizures
    Rosenfeld, W.
    Fountain, N.
    Kaubrys, G.
    Heinzen, L.
    McShea, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 13 - 14
  • [37] Lacosamide Monotherapy for the Treatment of Partial-Onset Seizures: Post-Hoc Analysis of Responder Rates from a Multicenter, Open-Label Extension Trial
    Vossler, David
    Wechsler, Robert
    Williams, Paulette
    Bymes, William
    Therriault, Sheila
    NEUROLOGY, 2016, 86
  • [38] LONG-TERM ADJUNCTIVE LACOSAMIDE IN PATIENTS WITH UNCONTROLLED PARTIAL-ONSET SEIZURES: RESULTS FROM THE SP774 PHASE III OPEN-LABEL EXTENSION TRIAL
    Rosenow, F.
    Kelemen, A.
    Ben-Menachem, E.
    McShea, C.
    Isojarvi, J.
    Doty, P.
    EPILEPSIA, 2011, 52 : 156 - 156
  • [39] Lacosamide: Safety and tolerability of adjunctive intravenous lacosamide as short-term replacement for oral lacosamide in subjects with partial-onset seizures during 30-, 15-, and 10-minute infusions
    Krauss, G.
    Ben-Menachem, E.
    Mameniskiene, R.
    Vaiciene, N.
    Rudd, D.
    Brock, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 319 - 320
  • [40] Safety and efficacy of open-label rufinamide as adjunctive therapy in pediatric patients with partial seizures
    Litzinger, MJ
    Hanny, A
    EPILEPSIA, 1999, 40 : 114 - 114
12345